Navigation Links
Harwood Feffer LLP Announces Securities Class Action Lawsuit Against Puma Biotechnology, Inc. And Advises Shareholders To Contact Harwood Feffer LLP Prior To The Lead Plaintiff Deadline
Date:6/22/2015

NEW YORK, June 22, 2015 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) announces a class action lawsuit has been filed in the United States District court for the Central District of California against Puma Biotechnology, Inc. ("Puma" or the "Company") (NYSE: PBYI), for alleged violations of the federal securities laws. Investors who purchased or otherwise acquired Puma shares between July 23, 2014 and May 13, 2015, inclusive (the "Class Period"), have until August 3, 2015 to serve as lead plaintiff in the class action. The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

Puma is a biopharmaceutical company that focuses on in-licensing cancer drug candidates that have already undergone or completed clinical testing. The complaint alleges that Puma made false and/or misleading statements and/or failed to disclose in violation of the securities laws that: (1) the Company's New Drug Application ("NDA") filing would be for a positive early stage breast cancer indication, instead of the previously announced metastatic breast cancer; (2) Puma would need to submit additional safety data from preclinical carcinogenicity studies with its NDA filing, which Puma did not have; (3) the additional studies required would push the timeline for filing the NDA into the first quarter of 2016; (4) the Company overstated results from its Phase III ExteNET trial; and (5) as a result of the foregoing, Puma lacked a reasonable basis for their positive statements concerning the Company's outlook, as well as the ongoing ExteNET trial. When the truth was revealed, the stock dropped causing damage to investors.

If you are a shareholder who suffered a loss during the Class Period and wish to discuss this matter with us, or have any questions concerning your rights and interests with regard to this matter, please contact:

Benjamin Sachs-Michaels, Esq.
Robert I. Harwood, Esq.
Harwood Feffer LLP
488 Madison Avenue
New York, New York 10022
Phone Numbers: (877) 935-7400
(212)935-7400
Email: bsachsmichaels@hfesq.com
Website: http://www.hfesq.com
Follow us on Twitter: @HarwoodFeffer

Harwood Feffer has been representing individual and institutional investors for many years, serving as lead counsel in numerous cases in federal and state courts. Please visit the Harwood Feffer LLP website (http://www.hfesq.com) for more information about the firm.

Attorney Advertising. The law firm responsible for this advertisement is Harwood Feffer LLP (www.hfesq.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Logo - http://photos.prnewswire.com/prnh/20120215/MM54604LOGO

 


'/>"/>
SOURCE Harwood Feffer LLP
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Harwood Feffer LLP Announces Investigation of Kythera Biopharmaceuticals, Inc.
2. Harwood Feffer LLP Announces Investigation of Geron Corporation
3. Harwood Feffer LLP Announces Investigation of Aerie Pharmaceuticals, Inc.
4. Harwood Feffer LLP Announces Investigation of Dietary Supplements Containing BMPEA
5. Harwood Feffer LLP Announces Investigation of Acadia Pharmaceuticals Inc.
6. Harwood Feffer LLP Announces Investigation of Advaxis, Inc.
7. Harwood Feffer LLP Announces Investigation of Avanir Pharmaceuticals, Inc.
8. Harwood Feffer LLP Announces Investigation of PDL BioPharma, Inc.
9. Harwood Feffer LLP Announces Investigation of Santarus, Inc.
10. Harwood Feffer LLP Announces Investigation of Transcept Pharmaceuticals, Inc.
11. Updated: Harwood Feffer LLP Announces Investigation of Edwards Lifesciences Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2019)... ... 2019 , ... Drs. Nickelice Brand and Chris Williams restore smiles of Ocala, ... office. Dental implants are a nearly permanent, comfortable and efficient way for patients to ... success rate when placed by highly trained professionals such as Drs. Brand and Williams, ...
(Date:9/17/2019)... ... 17, 2019 , ... Gustavo Grodnitzky, PhD will join the faculty of The ... holistic mind/body medicine for physicians and other health care professionals. Entitled The Heart ... the Cranwell Resort and Spa in Lenox, Massachusetts, is accredited by the Albany Medical ...
(Date:9/14/2019)... ... September 13, 2019 , ... Braun Industries, Crestline Coach Ltd, ... of service and wish him well on his retirement. Braun Industries and Crestline Coach ... to contact them direct for inquires related to new ambulance sales and service. ...
Breaking Medicine Technology:
(Date:9/17/2019)... ... September 17, 2019 , ... Six Consulting Inc. (SIX) ... of canines – specifically golden retrievers - through innovative cancer prevention medicine. A ... – one out of five retrievers in the United States will die from ...
(Date:9/17/2019)... ... , ... Lubin Austermuehle, P.C. will be one of the sponsors ... held at Found Kitchen and Social House in Evanston on Monday, October 7 from ... Disorder, a rare condition that results from changes to the GRIN2B gene. The GRIN2B ...
(Date:9/17/2019)... ... September 17, 2019 , ... ... services, welcomes Dr. Yevgeniya (Jenny) Gartshteyn to their team of expert physicians. Dr. ... previously held the Clinical Appointment of Assistant Professor in Medicine for the Division ...
(Date:9/11/2019)... ... September 12, 2019 , ... “Heart Seizures”: a useful source ... artery disease as he hopes to prevent anyone from having it and to help ... John Saltwick, a writer who was diagnosed with coronary artery disease. Predicted to experience ...
(Date:9/11/2019)... ... September 11, 2019 , ... ... at the 2019 AHIMA Health Data and Information Conference in Chicago, Illinois September ... booth #505 to learn more about GRM’s healthcare information management solutions . ...
Breaking Medicine News(10 mins):